As of 2024-12-15, the Relative Valuation of Finch Therapeutics Group Inc (FNCH) is (24.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.80 USD, the upside of Finch Therapeutics Group Inc based on Relative Valuation is -1434.8%.
The range of the Relative Valuation is (24.89) - (25.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.1x | 17.3x |
| Forward P/E multiples | 18.8x - 19.2x | 19.0x |
| Fair Price | (24.89) - (25.36) | (24.03) |
| Upside | -1482.6% - -1509.1% | -1434.8% |
| Date | P/E |
| 2024-12-11 | -8.87 |
| 2024-12-10 | -8.87 |
| 2024-12-09 | -8.91 |
| 2024-12-06 | -8.53 |
| 2024-12-05 | -8.88 |
| 2024-12-04 | -8.88 |
| 2024-12-03 | -9.16 |
| 2024-12-02 | -8.88 |
| 2024-11-29 | -9.07 |
| 2024-11-27 | -9.07 |
| 2024-11-26 | -8.96 |
| 2024-11-25 | -8.99 |
| 2024-11-22 | -9.10 |
| 2024-11-21 | -8.65 |
| 2024-11-20 | -8.65 |
| 2024-11-19 | -8.61 |
| 2024-11-18 | -8.45 |
| 2024-11-15 | -8.46 |
| 2024-11-14 | -9.07 |
| 2024-11-13 | -8.50 |
| 2024-11-12 | -8.69 |
| 2024-11-11 | -8.84 |
| 2024-11-08 | -8.91 |
| 2024-11-07 | -8.69 |
| 2024-11-06 | -9.07 |
| 2024-11-05 | -9.10 |
| 2024-11-04 | -9.03 |
| 2024-11-01 | -9.18 |
| 2024-10-31 | -9.07 |
| 2024-10-30 | -8.99 |
| 2024-10-29 | -8.69 |
| 2024-10-28 | -8.88 |
| 2024-10-25 | -9.03 |
| 2024-10-24 | -9.07 |
| 2024-10-23 | -9.07 |
| 2024-10-22 | -9.18 |
| 2024-10-21 | -9.28 |
| 2024-10-18 | -9.10 |
| 2024-10-17 | -9.10 |
| 2024-10-16 | -9.10 |
| 2024-10-15 | -9.07 |
| 2024-10-14 | -8.80 |
| 2024-10-11 | -8.69 |
| 2024-10-10 | -8.69 |
| 2024-10-09 | -8.69 |
| 2024-10-08 | -8.69 |
| 2024-10-07 | -8.69 |
| 2024-10-04 | -8.83 |
| 2024-10-03 | -8.91 |
| 2024-10-02 | -8.99 |